Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Cash from Operations (2019 - 2025)

Pulmonx has reported Cash from Operations over the past 7 years, most recently at 8192000.0 for Q3 2025.

  • Quarterly Cash from Operations fell 13.78% to 8192000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 32029000.0 through Sep 2025, up 3.53% year-over-year, with the annual reading at 31537000.0 for FY2024, 16.12% up from the prior year.
  • Cash from Operations was 8192000.0 for Q3 2025 at Pulmonx, down from 3900000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 3900000.0 in Q2 2025 and troughed at 15026000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 9564000.0 (2022), against an average of 9521684.21.
  • Year-over-year, Cash from Operations tumbled 64.94% in 2021 and then surged 32.82% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 10700000.0 in 2021, then increased by 8.36% to 9806000.0 in 2022, then grew by 14.34% to 8400000.0 in 2023, then grew by 19.8% to 6737000.0 in 2024, then decreased by 21.6% to 8192000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Cash from Operations are 8192000.0 (Q3 2025), 3900000.0 (Q2 2025), and 13200000.0 (Q1 2025).